SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891293-16-000089
Filing Date
2016-01-13
Accepted
2016-01-13 16:35:24
Documents
3
Period of Report
2016-01-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form_8-knewbvfdirector.htm 8-K 31694
2 EXHIBIT 99.1 exhibitperryappointment.htm EX-99.1 12071
3 logo.jpg GRAPHIC 11087
  Complete submission text file 0000891293-16-000089.txt   55112
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 161341099
SIC: 2834 Pharmaceutical Preparations